Precision Medicine for Acute Illness
Every patient is different. Treatment should be too.
Care for critical conditions in acute care settings should not be one-size-fits-all. Our mission is to tailor healthcare to each patient’s biology by creating and delivering integrated diagnostics and therapeutics.
Biological Insights to Deliver the Right Therapy
Sepsis. Pneumonia. ARDS. Acute kidney injury. Acute heart failure.
Every patient reacts differently to these conditions. And patients who appear to be stable can become critically ill in a matter of hours.
Why? Because each person is different and these conditions move fast.
At Prenosis, we aim to quickly deliver targeted treatment based on each patient’s underlying biology.

The Science Behind the Mission
Healthcare Tailored to Biology
Our precision medicine platform is purpose-built for acute care. It makes fast-moving biology visible, actionable, and treatable in near real time.
Powered by a constantly expanding biobank and multimodal dataset, our proprietary biological map of immune-driven disease connects clinical insight directly to targeted intervention.
The science that makes targeted treatment possible
Our research and data engine draws on one of the largest acute illness biobanks in existence, a growing network of leading clinical research sites, and AI that translates complex biology into actionable clinical information, all continuously refined as our dataset grows.
A platform built for diagnosis and treatment
Our Immunix® platform powers the development of integrated diagnostics and targeted therapeutic interventions. The initial commercial launch in our development pipeline is the Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis.
Research and evidence to drive improvement for critical illness
We have re-imagined the methodology behind clinical trials for critical conditions, using a fundamentally unique approach. By using underlying biology to quickly find the right patients, we can tailor trials for targeted interventional therapies.
In The News





